Colchicine and Inflammation in Hemodialysis Patients
Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
Chronic, low-grade inflammation is regarded as a common comorbid condition in chronic
dialysis patients.
Increased inflammatory markers in chronic dialysis patients are associated with adverse
clinical outcomes .
Considering the association of low-grade inflammation with high rate of morbidity and
mortality we decided to evaluate the anti inflammatory effect of colchicine on inflammatory
markers in hemodialysis patients